Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • CFANU
    Junior Member
    • Aug 2017
    • 2

    EMBL Australia Partner Laboratory Group Leader in Bioinformatics.

    http://jobs.anu.edu.au/cw/en/job/521...bioinformatics

    Expressions of interest are invited from bioinformatics and data analysis researchers who wish to advance their academic career as an EMBL Australia Partner Laboratory Group Leader hosted at the Department of Genome Sciences at The John Curtin School of Medical Research (JCSMR), The Australian National University (ANU). The successful applicant will have the opportunity to build their research team as well as collaborating with experimentalist colleagues to advance bioinformatics in different biomedical research contexts.

    JCSMR is a multidisciplinary biomedical research institution situated within the leafy ANU campus in central Canberra, Australia’s national capital. It supports a vibrant culture of academic enquiry across four departments focussing on the immunology and infectious disease, cancer, neuroscience as well as genome biology. EMBL Australia is a scientific network consisting of partner laboratories that are embedded with premier research institutions around Australia. It further links Australian research with EMBL in Europe and the European Bioinformatics Institute.

    Benefits:
    • Excellent, nurturing scientific environment;
    • State-of-the-art laboratories and access to leading-edge core research facilities, including the National Computational Infrastructure Facility;
    • Provision of core research funding and support;
    • Competitive terms and conditions, including relocation, removal and travel benefits. Salary packaging is also available for certain items;
    • A range of professional development programs, support for research, study and overseas work; and
    • ANU offers generous parental leave and flexible working arrangements. It is also an inaugural member of the Science in Australia Gender Equity (SAGE) Pilot Program that aims to address gender equity in Science, Technology, Engineering, Mathematics and Medicine (STEMM).

    • 5 years contract with the possibility of a 4 year extension



    Excellent benefits including EMBL loadings.
    Excellent support for academics who have family committments.
    Generous parental leave provisions, and,
    A community of academics who are aware of the needs of primary carers in an academic research position.


    Applicants:

    Applicants will be expected to have an exceptional international research profile in bioinformatics, data analysis, and an innovative research program that includes machine learning and / or AI, an excellent publication output, including recent discoveries published in high-profile scientific journals, and a highly successful record obtaining competitive funding.
    If you have the qualifications and high-level experience required to lead a new team of researchers in bioinformatics, we welcome your application.
    The ANU is highly supportive of, and encourages, applications from females and minority groups.

    There will be no responses to replies on this forum, please see ANU website for contact details.
    Last edited by CFANU; 02-14-2018, 01:03 PM.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...